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Ⅰ．Introduction
 An adequate adaptive immune response is essential 
to maintain homeostasis, modulate the microbiome, 
clear invasive foreign pathogens, and prevent cancer 
development, allergy, and autoimmunity. An insufficient 
immune response leads to uncontrolled pathogen 
invasion and cancer development. Conversely, an 
excessive immune response causes host damage, allergy, 
and autoimmunity. Thus, an appropriate CD4＋ helper 
T cell （Th cell） response including specific cytokine 
production, the number of expanding cells, and the 
timing of inflammation resolution must be finely tuned. 
However, how these T cell fates are appropriately 
regulated is largely unknown［1］.
 Th cells play central roles in adaptive immunity. 
When naïve CD4＋ T cells recognize antigens on the 
major histocompatibility complex （MHC） class II 
via the T cell receptor （TCR）, they proliferate and 
differentiate into specific Th cell subsets ［Th1, Th2, 
Th9, Th17, follicular helper T （Tfh）, and regulatory 
T （Treg） cells］. These cells are characterized by the 
expression of specific transcription factors （TFs）, which 
are called as “master regulators”, the production of a 
series of cytokines, and effector functions［2］. Antigen 
amounts and affinities for the TCR create a gradient of 
TCR signal strengths, which controls diverse T cell fates 
such as levels of expansion, activation status including 
exhaustion, various gene expression profiles, and Th 
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Abstract
For an adequate response to several types of invasive pathogens, CD4＋ T cells differentiate into 
helper T cell subsets with a specific function and mediate sequential immune responses. Antigen dose 
and affinity, as well as cytokines derived from innate immune cells, determine T cell fates including 
their diverse gene expression profiles and Th subset differentiation; however, the precise molecular 
mechanisms underlying such processes are still unknown. Interferon regulatory factor 4 （IRF4） and 
basic leucine zipper transcription factor, ATF-Like （BATF）, are expressed in hematopoietic cells. IRF4 
and BATF form complexes that play pivotal roles in Th2, Th9, Th17, and Tfh cell differentiation via the 
regulation of chromatin accessibility, the recruitment of other transcription factors, and the induction 
of downstream genes including master regulators. Moreover, a recent study revealed that IRF4⊖BATF 
complexes act as the sensor for TCR signal strength and tune the diverse transcriptional program. 
This review highlights the pivotal roles of IRF4 and BATF complexes in T cell fate and their molecular 
mechanisms.
　Key words:  IRF4⊖BATF complex, Th subset differentiation, TCR signal strength, epigenome, pioneer 
factor
72 Arifumi Iwata
subset differentiation［3］. Recent studies have elucidated 
the importance of two TFs, interferon regulatory factor 
4 （IRF4） and basic leucine zipper transcription factor, 
ATF-Like （BATF）, in Th subset differentiation［4,5］, as 
well as the diverse outcomes derived from graded TCR 
strength［6,7］. This review highlights the crucial role of 
IRF4 and BATF complexes in T cell fates, in addition to 
the underlying molecular mechanisms.
Ⅱ．Molecular features of IRF4 and BATF
IRF4
 IRF4 is a member of the interferon regulatory factor 
（IRF） family. It has two domains, a DNA binding 
domain （DBD） and an IRF association domain, which 
are separated by a flexible linker. DBDs of all IRFs 
recognize and bind the core sequence GAAA, but IRF4 
has only weak binding affinity. For stable transcriptional 
activity, IRF4 requires interactions with other TFs such 
as PU.1, SPI-B, BATF, signal transducer and activator of 
transcription （STATs）, nuclear factor of activated T cells 
（NFATs）, RAR-related orphan receptor-γt （ROR-γt）, 
SMADs, B-cell lymphoma 6 （BCL-6）, and forkhead 
box P3 （Foxp3）［4］. IRF4 expression is restricted to 
hematopoietic cells and unlike other IRFs, its expression 
is not induced by interferon, but rather by other factors 
such as IL-4, lipopolysaccharide, and TCR signals［4］. 
IRF4 regulates class switch recombination in B cells, 
plasma cell development, Th subset differentiation, the 
expansion and effector function of CD8＋ T cells, and the 
development of cDC2s, which are also known as IRF4-
dependent dendritic cells （DCs）［8］.
BATF
 BATF is a basic leucine zipper （bZIP） transcription 
factor of the activator protein-1 （AP1） family. BATF, 
BATF2, and BATF3 comprise the BATF subfamily. 
BATF has a bZIP domain, which contains a basic DNA-
binding region and a leucine zipper region, but no 
transactivation domain. All BATF subfamily members 
heterodimerize with JUN family proteins such as 
c-JUN, JUNB, and JUND. BATF⊖JUN heterodimers 
recognize and bind TPA response elements with TGA 
（C/G） TCA motifs. BATF expression is also restricted 
to hematopoietic cells such as T cells, B cells, and DCs. 
BATF is induced by stimulation with IL-1, IL-4, IL-
6, GM-CSF, and TCR signals and plays crucial roles 
in class switch recombination in B cells, Th subset 
differentiation, and the effector function of CD8 T cells
［5］. BATF3, a member of the BATF subfamily, is 
predominantly expressed in DCs and their progenitors 
and is also expressed in activated T cells. BATF3 
compensates for the function of BATF. Therefore, the 
roles of BATF have been underestimated in Batf －/－ 
mice［5,6］.
Formation of the IRF4⊖BATF complex
 In B cells and DCs, IRF4 mainly interacts with PU.1 
or SPI-B and binds Ets-interferon composite elements 
（EICEs） with GGAAnnGAAA motifs （‘n’ indicates 
any nucleotide）. However, IRF4 in T cells mainly 
interacts with BATF, due to the low expression of 
PU.1 and SPI-B, and binds AP-1-interferon composite 
elements （AICEs） such as AICE1 ［TTTCnnnnTGA 
（C/G） TCA］ and AICE2 ［GAAATGA （C/G） TCA］
［9,10］. IRF4 binding capacity in T cells completely 
depends on interactions with BATF because IRF4 in 
Batf－/－ T cells cannot bind genomic DNA. Similarly, 
BATF binding is significantly reduced in Irf4－/－ T 
cells［6,9,10,11］. Therefore, the formation of IRF4⊖
BATF⊖DNA complexes is critical for stable binding and 
transcriptional activity.
Ⅲ．IRF4 and BATF regulate Th differentiation
 The mucosal barrier and innate immune cells, upon 
encountering various pathogens and stimuli, establish 
an appropriate microenvironment via the production 
of a series of cytokines. This environment induces 
the expression of lineage-specific TFs and master 
regulators in activated CD4＋ T cells and promotes Th 
subset differentiation, which is important for sequential 
immune responses （Fig. 1）［2］.
Th1  cells
 IL-12, produced by antigen-presenting cells, induces 
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activation of the lineage-specific TF STAT4 in T cells. 
Activated T cells express the master regulator T-bet, 
produce interferon-gamma （IFN-γ）, and differentiate 
into Th1 cells, which protect the host from intracellular 
bacteria and virus infection. Both Irf4－/－ and Batf/
Batf3 -double deficient CD4＋ T cells normally express 
IFN-γ under Th1 conditions in vitro. Therefore, T-bet 
and IFN-γ in Th1 cells are not regulated by IRF4 or 
BATF［4,12］.
Th2  cells
 Th2 cells are induced by IL-4, activate STAT6, 
express GATA-binding protein 3 （GATA3）, produce 
type 2 cytokines such as IL-4, IL-5, and IL-13, and play 
critical roles in helminth expulsion and allergy. Irf4－/－ 
CD4＋ T cells fail to develop into Th2 cells in vitro 
and in vivo［4］. Similarly, Batf/Batf3 -double deficient 
T cells stimulated with Th2 culture conditions fail to 
produce type 2 cytokines［6,12］. ChIP-seq analysis, 
reported by several groups, showed that both IRF4 and 
BATF bind the promoter and enhancer around key genes 
of Th2 cell such as Gata3 , growth factor independent 
1, Il4 , Il10 , and cytotoxic T-lymphocyte-associated 
protein 4 （Ctla4）. Indeed, in a murine model of asthma, 
Batf －/－ mice show reduced asthmatic features including 
eosinophil infiltration, airway hyperresponsiveness, and 
type 2 cytokine production in the lung［13］. Therefore, 
IRF4 and BATF play indispensable roles in Th2 cell 
differentiation. Recently, it was shown that BTB and 
CNC homology, basic leucine zipper transcription 
factor 2 （BACH2）, which is a well-known negative 
regulator of effector differentiation, physically interacts 
with BATF. BATF⊖BACH2 complexes suppress Th2 
differentiation by interfering with the formation of 
IRF4⊖BATF complexes on AICEs［14］.
Th9  cells
 Th9 cells develop from naïve CD4 T cells stimulated 
by IL-4 and transforming growth factor-β （TGF-
β）. These cytokines activate STAT6 and SMAD2/3, 
induce PU.1 and IRF4, and induce the production of IL-
9. Th9 cells play a pathogenic role in allergic diseases
［4］. IRF4 and BATF cooperatively bind the Il9  gene 
and induce IL-9 production; moreover, both Irf4－/－ 
and Batf －/－ T cells exhibit reduced IL-9 production 
under Th9 conditions. However, the regulation of Th9 
differentiation by IRF4 and BATF is very complicated. 
PU.1 is highly expressed in Th9 cells, and thus, IRF4 
might function by binding EICEs with PU.1［4］. 
Further, BATF deficiency has a greater influence on the 
expression of Th9-associated genes than IRF4 deficiency, 
and the overexpression of BATF can induce IL-9 
production in Irf4－/－ T cells［15］. Furthermore, BATF⊖
BACH2 complexes promote IL-9 production in Th9 
cells［16］. Therefore, IRF4 and BATF co-operatively or 
independently contribute to Th9 differentiation.
Th17  cells
 Th17 cells are induced by IL-6 and TGF-β, express 
RORγt, produce IL-17, protect the host from bacteria 
and fungi, and are also related to autoimmunity. 
The roles of IRF4 and BATF in these cells are well 
established. Irf4－/－ and Batf －/－ T cells fail to develop 
into Th17 cells in vitro. In addition, Irf4－/－ and 
T-bet GATA3
IRF4/BATF
IL-4 RORγt
IRF4/BATF
IL-17
Th1 Th2 Th17
Th9 Treg Tfh
PU.1
IRF4/BATF
IL-9 Foxp3
IRF4   BATF
ICOS
IRF4/BATF
cMAFBCL-6
IRF4/BATF
?
Naive
IL-12
IL-4
IL-6 + TGFβ
IL-4 + TGFβ IL-6
TGFβ
IFN-γ
?
Fig. 1　Th subsets and the IRF⊖BATF complex
　When naïve CD4＋ T cells are activated, microenvironment-
derived cytokines induce the differentiation of naïve CD4＋ 
T cells to distinct Th subsets. Six different Th subsets are 
characterized by the expression of master regulators （depicted 
as bold） and effector molecules. IRF4 and BATF regulate 
some master regulators and effector molecules cooperatively 
or independently. 
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Batf－/－ mice are resistant to experimental autoimmune 
encephalomyelitis, of which the development depends 
on Th17 cells［4,5］. Both IRF4 and BATF directly bind 
AICEs around Th17-associated genes such as Il17 , 
Il21 , Il22 , Il23r, and Rorc, encoding RORγt. Therefore, 
IRF4⊖BATF complexes play fundamental roles in Th17 
differentiation and the detailed molecular mechanisms 
are described as follows.
Treg cells
 Treg cells, which are defined based on the expression 
of Foxp3, produce IL-10 and TGF-β, express CTLA-4, 
maintain immunological self-tolerance and homeostasis, 
and protect the host from excessive inflammation, 
autoimmunity, and allergy. Treg cell-specific Irf4－/－ 
mice show several features of autoimmune disease, 
such as lymphadenopathy, weight loss, blepharitis, and 
dermatitis. These mice also exhibit a slight increase in 
the Treg population in lymphoid tissue. Irf4－/－ Treg cells 
express the same levels of Foxp3 as compared to those in 
WT Treg cells and possess suppression capacity in vitro, 
but in these cells, 80% of Treg-associated genes, such as 
Icos, Il10 , Maf, and Ccr8 , are downregulated. Thus, IRF4 
in Treg cells regulates a specific transcriptional program 
involved in the effector function of these cells［17］. In 
contrast, BATF deficiency reduces the number of splenic 
Treg cells. A recent report showed that BATF regulates 
the development of one Treg cell subtype, specifically 
CD4＋Foxp3＋CD44highCCR7lowKLRG1＋ST2＋ Treg cells
［18］. However, it is still unclear whether IRF4 and BATF 
in Treg cells function independently or cooperatively and 
thus, further studies are needed.
Tfh cells
 Tfh cells express C-X-C chemokine receptor 
type 5 （CXCR5） and programmed cell death 1 （PD-
1）, are located in the B cell zone and germinal center 
of lymphoid tissue, help B cells to undergo affinity 
maturation through somatic hypermutation, and promote 
class switch recombination during the germinal center 
reaction. Tfh cells are induced by IL-6/IL-21-STAT3 
signals, are suppressed by IL-2-STAT5 signals, express 
the master regulator BCL-6, and produce a large amount 
of IL-21. Interestingly, Irf4－/－ mice fail to develop Tfh 
cells and germinal center B cells. Further, although IRF4 
has a great impact on B cell maturation, Irf4－/－ T cells 
are not able to express BCL-6 and IL-21 in a T cell-
intrinsic manner［4］. As with Irf4－/－ mice, Batf －/－ mice 
lack germinal center formation and Tfh cell development 
capacity. BATF directly regulates the expression of 
BCL-6 and c-MAF, which are critical TFs for Tfh cell 
development. However, the reconstitution of BCL-6 and 
c-MAF in Batf－/－ Tfh cells restore Tfh cell functions 
to support germinal center B cells. Thus, IRF4⊖BATF 
complexes function as inducers of BCL-6 and c-MAF 
during Tfh development［5］.
Ⅳ．IRF4 and BATF function as pioneer factors
 IRF4 and BATF are indispensable for the induction 
of different genes in diverse Th subsets. Ciofani et 
al. explored the molecular mechanisms underlying 
Th17 development using hundreds of next generation 
sequencing data including ChIP-seq, FRARE-seq, and 
RNA-seq obtained from WT and TF-deficient Th0, 
Th1, Th2, and Th17 cells［11］. They identified critical 
functions of IRF4⊖BATF complexes with respect to Th17 
differentiation and TF networks among IRF4, BATF, 
STAT3, RORγt, and c-Maf. IRF4⊖BATF complexes 
occupied inducible open chromatin that was accessible 
in Th17 cells but not in naïve CD4 T cells. Further, the 
FRARE-seq signals on inducible open chromatin were 
markedly reduced in Irf4－/－ or Batf－/－ T cells and the 
binding of STAT3, RORγt, and c-Maf to these regions 
was almost entirely abolished in Irf4－/－ or Batf－/－ T 
cells. Moreover, STAT3 was found to bind part of these 
open regions and to induce downstream genes including 
Rorc and Maf. Subsequently, it was demonstrated that 
RORγt binds Th17-associated genes. In addition, IRF4, 
BATF, STAT3, and RORγt cooperatively amplify the 
induction of target genes including themselves （Fig. 
2）. c-Maf acts as a transcriptional repressor of the 
aforementioned four TFs. Importantly, open chromatin 
develops not only in Th17 cells but also in Th0 cells. 
Therefore, IRF4⊖BATF complexes alter the chromatin 
landscape and facilitate the subsequent recruitment of 
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of rapamycin （mTOR） pathway induce proportional 
IRF4 expression relative to TCR signal strength［3,19］. 
The levels of IRF4 in CD8＋ T cells directly regulate 
the graded outcomes, clonal expansion, and effector/
memory fate［19］. In CD4＋ T cells, levels of IRF4 and 
BATF are upregulated by TCR stimulation that reflects 
the signal strength, as is the case for IRF4 in CD8＋ T 
cells［6］. Recently, how different levels of IRF4⊖BATF 
complexes are translated into T cell fates was elucidated. 
IRF4⊖BATF-dependent genes show two distinct 
sensitivity patterns to IRF4⊖BATF complex levels. 
Specifically, high sensitivity genes including Gata3 , 
Prdm1 , and Maf are sensitive to low amounts of IRF4⊖
BATF, whereas low sensitivity genes including Ctla4 , 
Pparg, and Il12 rb2  require high amounts of IRF4⊖
BATF［6］. In addition, ChIP-seq analysis revealed that 
all IRF4⊖BATF-binding sites are not equivalent based on 
the grade of TCR strength. Low levels of IRF4⊖BATF 
complexes preferentially bind high-affinity enhancer 
elements, which are located around high sensitivity 
genes; thus, these genes are induced by low numbers of 
IRF4⊖BATF complexes. When IRF4⊖BATF complexes 
accumulate due to the presence of strong signals, they 
can bind low-affinity enhancer elements, subsequently 
inducing low sensitivity genes. Importantly, the affinity 
of enhancer to IRF4⊖BATF complexes is defined by 
the flanking sequence around core AICEs （Fig. 3）［6］. 
Indeed, the fate choice between effector T cells and Tfh 
cells in vivo is determined by the affinity of Bcl6  and 
Prdm1  loci to IRF4［7］. In humans, a single-nucleotide 
polymorphism （SNP）, rs231735-T, which was reported 
to be a protective SNP for some autoimmune diseases, 
is located around CTLA4  gene and comprises a flanking 
AICE region. This SNP alters the affinity of AICE, from 
low-affinity to high-affinity, and increases enhancer 
activity via the sensitivity required for TCR stimulation, 
which might lead to higher and earlier expression of 
CTLA-4 under inflammatory conditions compared to 
that in patients without the SNP; thus, this SNP could 
protect against autoimmune diseases［6］. Considering 
that most of human SNPs are located in non-coding 
regions, further studies on SNPs and alterations in 
affinity for TFs are needed.
lineage-specific TFs to the regulatory elements of Th 
subset-associated genes; thus, IRF4⊖BATF complexes are 
able to function as pioneer factors in different Th subsets
［11］.
Ⅴ．IRF4⊖BATF complex levels control T cell fate
 T cells adjust the levels of their clonal expansion and 
effector cytokine responses according to the level and 
type of microbial invasion［1］. Excessive expansion and 
activation cause host damage; therefore, T cells should 
sense the information about the dose and affinity of the 
antigen to generate adequate responses and implement a 
negative regulatory system such as inhibitory molecules 
like CTLA-4. Thus, TCR signal strength regulates T cell 
fates including not only their activation but also Th1⊖
Th2, Th17⊖Treg, and effector T⊖Tfh balances. Weak 
TCR signals favor the induction of Th2, Treg, and Tfh 
cell differentiation, whereas strong signals lead to Th1, 
Th17, and effector T cell differentiation［3］. TCR signals 
initially induce kinase cascades in a digital manner; 
however, the accumulation of downstream signaling 
cascades including the inducible T cell kinase （ITK）/
Ca influx/NFAT pathway and the Atk/mammalian target 
A
BATF
IRF4
BATF
IRF4
B
LSTF
MR
LSTF
MR
BATF
IRF4
TG
BATF
IRF4
C
LSTF
MR
MR
BATF
IRF4
TG
M
R
BATF
IRF4
TG
Fig. 2　 IRF⊖BATF complexes open the chromatin to 
initiate a lineage-specific program
　（A） IRF4⊖BATF complexes bind closed chromatin and 
open the chromatin. （B） Lineage-specific transcription 
factors （LSTFs） are subsequently recruited to opened 
chromatin. LSTF and IRF4⊖BATF complexes cooperatively 
induce a subset of specific master regulators （MRs）. （C） 
MR, LSTF, and IRF4⊖BATF complexes fully activate target 
gene （TG） loci.
76 Arifumi Iwata
Contributors
 AI wrote this manuscript and produced the figures.
Acknowledgments
 I would like to express my gratitude to Prof. Hiroshi 
Nakajima for critically reading the manuscript. I thank 
Prof. Kenneth Murphy and Dr. Theresa Murphy for their 
support and discussion. I also thank Dr. Hiroki Furuya 
for his constructive comments and feedback. 
Conflict of interest
 The author declares no conflicts of interest associated 
with this manuscript.
References
1 ） Mayya V, Dustin ML. （2016） What scales the T cell 
response? Trends Immunol 37, 513-22.
2） Saravia J, Chapman NM, Chi H. （2019） Helper T cell 
differentiation. Cell Mol Immunol 16, 634-43.
3 ） Morel PA. （2018） Differential T-cell receptor signals for 
T helper cell programming. Immunology 155, 63-71.
4 ） Huber M, Lohoff M. （2014） IRF4 at the crossroads of 
effector T-cell fate decision. Eur J Immunol 44, 1886-95.
5 ） Murphy TL, Tussiwand R, Murphy KM. （2013） 
Specificity through cooperation: BATF-IRF interactions 
control immune-regulatory networks. Nat Rev Immunol 
2013 13, 499-509.
6 ） Iwata A, Durai V, Tussiwand R, Briseño CG, Wu X, 
Grajales-Reyes GE, Egawa T, Murphy TL, Murphy 
KM. （2017） Quality of TCR signaling determined by 
differential affinities of enhancers for the composite 
BATF-IRF4 transcription factor complex. Nat Immunol 
18, 563-72.
7 ） Krishnamoorthy V, Kannanganat S, Maienschein-Cline 
M, Cook SL, Chen J, Bahroos N, Sievert E, Corse 
E, Chong A, Sciammas R. （2017） The IRF4 gene 
regulatory module functions as a read-write integrator to 
dynamically coordinate T helper cell fate. Immunity 47, 
481-97.e7.
8 ） Nam S, Lim JS. （2016） Essential role of interferon 
regulatory factor 4 （IRF4） in immune cell development. 
Arch Pharm Res 39, 1548-55.
9 ） Li P, Spolski R, Liao W, Wang L, Murphy TL, Murphy 
KM, Leonard WJ. （2012） BATF-JUN is critical for 
IRF4-mediated transcription in T cells. Nature 490, 543-
6.
10） Glasmacher E, Agrawal S, Chang AB, Murphy TL, Zeng 
Ⅵ．Concluding remarks and future directions
 Recent studies have revealed how CD4＋ T cell fates 
are tightly tuned. IRF4⊖BATF complexes play central 
roles in T cell fate; however, BATF⊖BACH2 has also 
been implicated in this process in the context of IRF4⊖
BATF. BATF⊖BACH2 complexes function as positive 
regulators of IL-9 production but also as antagonists of 
IRF4⊖BATF complexes on the Il4  promoter. BACH2 
is well-known as the central repressor of effector T cell 
fate; therefore, interactions among IRF4, BATF, and 
BACH2 should be studied more intensely. Moreover, the 
pioneer factors involved in Th1 and Treg development 
are still unknown. Further work on the mechanism 
underlying T cell fate is thus needed.
TCR signal strength
BATFIRF4
G
en
e 
ex
pr
es
si
on
T T
G GLow sensitivity genes G G
T T
High sensitivity genes
Low sensitivity genes
High sensitivity genes
TCR signal strength
Fig. 3　TCR strength translates into diverse gene profiles
　Levels of TCR signal strength induce the proportional 
expression of IRF4⊖BATF complexes. Upon low-level 
stimulation, low levels of IRF4⊖BATF complexes preferentially 
bind high-affinity sites around high sensitivity genes. 
Therefore, a fraction of IRF4⊖BATF-dependent genes is 
expressed in response to low TCR signal strength. Increased 
TCR signal strength leads to the accumulation of IRF4⊖
BATF complexes. An abundance of complexes can result in 
the binding of low-affinity AICE sites. Subsequently, low-
sensitivity genes are induced. Therefore, gene expression 
profiles are regulated by TCR signal strength and the affinity 
of enhancer sites for IRF4⊖BATF complexes.
77IRF4⊖BATF complexes govern T cell fate
14） Yamashita M, Kuwahara M. （2018） The critical role of 
Bach2 in regulating type 2 chronic airway inflammation. 
Int Immunol 30, 397-402.
15） Jabeen R, Goswami R, Awe O, Kulkarni A, Nguyen ET, 
Attenasio A, Walsh D, Olson MR, Kim MH, Tepper RS, 
Sun J, Kim CH, Taparowsky EJ, Zhou B, Kaplan MH. 
（2013） Th9 cell development requires a BATF-regulated 
transcriptional network. J Clin Invest 123, 4641-53.
16） Fu Y, Koh B, Kuwahara M, Ulrich BJ, Kharwadkar R, 
Yamashita M, Kaplan MH （2019） BATF-interacting 
proteins dictate specificity in Th subset activity. J 
Immunol. pii: ji1900128.
17） Zheng Y, Chaudhry A, Kas A, deRoos P, Kim JM, Chu 
TT, Corcoran L, Treuting P, Klein U, Rudensky AY. 
（2009） Regulatory T-cell suppressor program co-opts 
transcription factor IRF4 to control T （H） 2 responses. 
Nature 458, 351-6.
18） Hayatsu N, Miyao T, Tachibana M, Murakami R, Kimura 
A, Kato T, Kawakami E, Endo TA, Setoguchi R, Watarai 
H, Nishikawa T, Yasuda T, Yoshida H, Hori S. （2017） 
Analyses of a mutant Foxp3 allele reveal BATF as a 
critical transcription factor in the differentiation and 
accumulation of tissue regulatory T cells. Immunity 47, 
268-83.
19） Conley JM, Gallagher MP, Berg LJ. （2016） T cells and 
gene regulation: The switching on and turning up of 
genes after T cell receptor stimulation in CD8 T cells. 
Front Immunol 7, 76.
W, Vander Lugt B, Khan AA, Ciofani M, Spooner CJ, 
Rutz S, Hackney J, Nurieva R, Escalante CR, Ouyang W, 
Littman DR, Murphy KM, Singh H. （2012） A genomic 
regulatory element that directs assembly and function 
of immune-specific AP-1-IRF complexes. Science 338, 
975-80.
11） Ciofani M, Madar A, Galan C, Sellars M, Mace K, Pauli 
F, Agarwal A, Huang W, Parkhurst CN, Muratet M, 
Newberry KM, Meadows S, Greenfield A, Yang Y, Jain 
P, Kirigin FK, Birchmeier C, Wagner EF, Murphy KM, 
Myers RM, Bonneau R, Littman DR. （2012） A validated 
regulatory network for Th17 cell specification. Cell 151, 
289-303.
12） Tussiwand R, Lee WL, Murphy TL, Mashayekhi M, KC 
W, Albring JC, Satpathy AT, Rotondo JA, Edelson BT, 
Kretzer NM, Wu X, Weiss LA, Glasmacher E, Li P, Liao 
W, Behnke M, Lam SS, Aurthur CT, Leonard WJ, Singh 
H, Stallings CL, Sibley LD, Schreiber RD, Murphy 
KM. （2012） Compensatory dendritic cell development 
mediated by BATF-IRF interactions. Nature 490, 502-7.
13） Übel C, Sopel N, Graser A, Hildner K, Reinhardt C, 
Zimmermann T, Rieker RJ, Maier A, Neurath MF, 
Murphy KM, Finotto S. （2014） The activating protein 
1 transcription factor basic leucine zipper transcription 
factor, ATF-like （BATF）, regulates lymphocyte- and 
mast cell-driven immune responses in the setting of 
allergic asthma. J Allergy Clin Immunol 133, 198-206.
e1-9.
